Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Australian Stock Exchange  >  Mayne Pharma Group Limited    MYX   AU000000MYX0

MAYNE PHARMA GROUP LIMITED

(MYX)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Stock Exchange
01/19/2021 01/20/2021 01/21/2021 01/22/2021 01/25/2021 Date
0.345 0.35 0.35 0.345 0.35 Last
624899 1113060 723111 1290016 1180457 Volume
-2.82% +1.45% 0.00% -1.43% +1.45% Change
Financials
Sales 2021 456 M 353 M 353 M
Net income 2021 -9,13 M -7,07 M -7,07 M
Net Debt 2021 254 M 197 M 197 M
P/E ratio 2021 -56,8x
Yield 2021 -
Sales 2022 550 M 426 M 426 M
Net income 2022 18,2 M 14,1 M 14,1 M
Net Debt 2022 234 M 181 M 181 M
P/E ratio 2022 30,8x
Yield 2022 -
Capitalization 588 M 455 M 455 M
EV / Sales 2021 1,84x
EV / Sales 2022 1,49x
Nbr of Employees 967
Free-Float 81,1%
More Financials
Company
Mayne Pharma Group Ltd is an Australia-based specialty pharmaceutical company. The Company is focused on commercializing branded and generic pharmaceuticals. It operates through four segments: Generic Products (GPD), Specialty Brands (SBD), Metrics Contract Services (MCS) and Mayne Pharma International (MPI). The GPD segment is engaged in the manufacture and distribution of generic pharmaceutical products in the... 
Sector
Pharmaceuticals
Calendar
02/19Earnings Release
More about the company
Notations Surperformance© of Mayne Pharma Group Limited
Trading Rating : Investor Rating :
More Ratings
All news about MAYNE PHARMA GROUP LIMITED
01/06MAYNE PHARMA : Launches Pregnancy Prevention Tablets in US
MT
01/06MAYNE PHARMA : launches Microgestin 24 FE tablets in the US
PU
01/06MAYNE PHARMA : 07/01/2021 Mayne Pharma launches Microgestin® 24 Fe tablets in th..
PU
2020MAYNE PHARMA : Extends Three-Year Bullet Facility
MT
2020MAYNE PHARMA : 18/12/2020 Mayne Pharma successfully extends debt facility
PU
2020MAYNE PHARMA : successfully extends debt facility
PU
2020MAYNE PHARMA : 24/11/2020 2020 AGM Chairman's Address
PU
2020MAYNE PHARMA : 24/11/2020 2020 AGM CEO's Speech
PU
2020MAYNE PHARMA : 09/11/2020 Mayne Pharma Board Renewal
PU
2020MAYNE PHARMA : Board Renewal
PU
2020MAYNE PHARMA : New data on Mayne Pharma's TOLSURA presented at IDWeek 2020
AQ
2020MAYNE PHARMA : 26/10/2020 New data on Mayne Pharma's TOLSURA presented at IDWeek..
PU
2020MAYNE PHARMA : Lapse of rights and AGM Notice of Meeting clarification
PU
2020MAYNE PHARMA : 2020 Annual General Meeting
PU
2020MAYNE PHARMA : 2020 Corporate Governance Statement
PU
More news
News in other languages on MAYNE PHARMA GROUP LIMITED
2020MAYNE PHARMA GROUP LIMITED : Veröffentlichung des Halbjahresergebnisses
2020MAYNE PHARMA GROUP LIMITED : publication des résultats semestriels
2019MAYNE PHARMA GROUP LTD : publication des résultats semestriels
2019MAYNE PHARMA GROUP LTD : Veröffentlichung des Halbjahresergebnisses
2018MAYNE PHARMA GROUP LTD : publication des résultats annuels
More news
Chart MAYNE PHARMA GROUP LIMITED
Duration : Period :
Mayne Pharma Group Limited Technical Analysis Chart | MYX | AU000000MYX0 | MarketScreener
Technical analysis trends MAYNE PHARMA GROUP LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Average target price 0,41 AUD
Last Close Price 0,35 AUD
Spread / Highest target 100%
Spread / Average Target 15,9%
Spread / Lowest Target -5,71%
EPS Revisions
Managers and Directors
NameTitle
Scott Richards Chief Executive Officer, MD & Executive Director
Roger Campbell Corbett Independent Non-Executive Chairman
Peter Paltoglou Chief Financial Officer
Bruce L. Mathieson Independent Non-Executive Director
Ian Frank Scholes Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
MAYNE PHARMA GROUP LIMITED1.45%452
MERCK KGAA1.92%75 424
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD15.70%28 816
KYOWA KIRIN CO., LTD.3.70%15 105
BETTA PHARMACEUTICALS CO., LTD.32.16%8 825
YUHAN CORPORATION-3.06%4 299